Opinion

Video

Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

The expert panel discusses how treatment strategies change based on cisplatin eligibility and the role of maintenance therapy in metastatic urothelial carcinoma.

Related Videos
Alan Tan, MD, Vanderbilt-Ingram Cancer Center
5 KOLs are featured in this series.
5 KOLs are featured in this series.
Chad Tang, MD
Jared Weiss, MD
5 KOLs are featured in this series.